Back
ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
ACAD
Sponsored
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
41
ACAD
ACADIA Pharmaceuticals
Last Price:
16.72
Seasonality Move:
5.15%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" projectACADIA Pharmaceuticals Price Quote
$16.72
+0.01 (+2.51%)
(Updated: April 27, 2024 at 5:51 AM ET)
ACADIA Pharmaceuticals Key Stats
Sell
41
ACADIA Pharmaceuticals (ACAD)
is a Sell
Day range:
$16.27 - $16.74
52-week range:
$16.16 - $33.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.77
P/B ratio:
6.38%
Volume:
1.2M
Avg. volume:
1.6M
1-year change:
-17.73%
Market cap:
$2.8B
Revenue:
$726.4M
EPS:
$-0.38
How Much Does ACADIA Pharmaceuticals Make?
-
How Much Are ACADIA Pharmaceuticals's Sales Annually?
ACAD Revenues are $726.4M -
How Much Profit Does ACADIA Pharmaceuticals's Make A Year?
ACAD net income is -$61.3M
Is ACADIA Pharmaceuticals Growing As A Company?
-
What Is ACADIA Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.69% -
What Is ACADIA Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ACADIA Pharmaceuticals Stock Price Performance
-
Did ACADIA Pharmaceuticals Stock Go Up Last Month?
ACADIA Pharmaceuticals share price went down by -6.07% last month -
Did ACAD's Share Price Rise Over The Last Year?
ACAD share price fell by -17.73% over the past 1 year
What Is ACADIA Pharmaceuticals 52-Week High & Low?
-
What Is ACADIA Pharmaceuticals’s 52-Week High Share Price?
ACADIA Pharmaceuticals has traded as high as $33.99 over the past 52 weeks -
What Is ACADIA Pharmaceuticals’s 52-Week Low Share Price?
ACADIA Pharmaceuticals has traded as low as $16.16 over the past 52 weeks
ACADIA Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ACADIA Pharmaceuticals?
-
How Much Debt Does ACADIA Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does ACADIA Pharmaceuticals Have?
Cash and short term investments quarterly total is $438.9M -
What Is ACADIA Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.62
Is ACADIA Pharmaceuticals Cash Flow Positive?
-
What Is ACAD Cash Flow From Operations?
Cash flow from operations (TTM) is $16.7M -
What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25.1M -
What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $32M
ACADIA Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
ACAD return on invested capital is -15.6% -
What Is ACADIA Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -9.38% -
What Is ACAD Return On Equity?
ROE is a measure of profitability and is -15.6%
ACADIA Pharmaceuticals Earnings Date & Stock Price
-
What Is ACADIA Pharmaceuticals's Stock Price Today?
A single share of ACAD can be purchased today for 16.71 -
What Is ACADIA Pharmaceuticals’s Stock Symbol?
ACADIA Pharmaceuticals trades on the nasdaq under the ticker symbol: ACAD -
When Is ACADIA Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for ACADIA Pharmaceuticals is scheduled on May 8, 2024 -
When Is ACAD's next ex-dividend date?
ACADIA Pharmaceuticals's next ex-dividend date is May 26, 2020 -
How To Buy ACADIA Pharmaceuticals Stock?
You can buy ACADIA Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ACADIA Pharmaceuticals Competitors
-
Who Are ACADIA Pharmaceuticals's Competitors?
Below is a list of companies who compete with ACADIA Pharmaceuticals or are related in some way:
ACADIA Pharmaceuticals Dividend Yield
Data Unavailable
ACADIA Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -9.51% |
Revenue: | 69.27% | 3.24% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 5 |
Sell Recommendations: | 0 |
Price Target: | 29.09 |
Upside from Last Price: | 74.11% |